Skip to main content
. 2017 Nov 7;14(11):e1002417. doi: 10.1371/journal.pmed.1002417

Fig 3. Changes in lymphocyte surface markers following ATI in PrEP Participant A and HSCT Participant B.

Fig 3

The percentage of CD8+ and CD4+ T cells expressing CD30 and CD69 are shown in (A) and (B). The percentage of CD16+ and CD56+ NK cells expressing CD30 and CD69 are shown in (C) and (D). T cell expression of CD30 from the allogeneic HSCT recipient who also underwent ATI is shown in (E). Abbreviations: ATI, analytical treatment interruption; c/mL, copies/mL; HSCT, hematopoietic stem cell transplantation; NK, natural killer; PrEP, pre-exposure prophylaxis.